EL-PFDD Meeting: Chemo-Induced Hearing Loss in Pediatrics

The first-ever childhood cancer-focused, externally-led patient focused drug development workshop for the FDA spotlighted the impact of chemotherapy-induced hearing loss. Personal testimony through panel discussions and commentary detailed the depth and spectrum of this impact. Learn more by reviewing the recording and Voice of the Patient Report.